Acción 3320 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas China Resources Pharmaceutical Group Limited

Acciones

3320

HK0000311099

Mercado cerrado - Hong Kong S.E.
Otros sitios de cotización
 10:09:00 03/05/2024 		Varia. Cinco días. Varia. 1 de enero.
5,22 HKD +2,96 % Gráfico intradía de China Resources Pharmaceutical Group Limited +3,57 % +1,75 %
24/04 China Resources Pharmaceutical Group Limited anuncia el cambio de secretario de la empresa CI
12/04 China Resources Dong-E-E-Jiao Company Limited proporciona una guía de ganancias para los tres meses que finalizan el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
China Resources Pharmaceutical Group Limited Announces Change of Company Secretary
China Resources Pharma Unit Issues 3 Billion Yuan Bonds
China Resources Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Three Months Ended 31 March 2024
China Resources Pharmaceutical Posts Gains in Full Year 2023 Profit
China Resources Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue
CR Sanjiu Expects Increase in 2023 Profit
China Resources Pharmaceutical Unit Completes Capital Increase; Shares Fall 3%
China Resources Pharmaceutical Unit Enters Share Subscription Deals to Boost Capital
China Resources Pharmaceutical Group Limited Announces Management Changes, Effective on 27 December 2023
China Resources Pharma Unit Boosts Stake in Jiangzhong Pharma Parent
China Resources Pharmaceutical Subsidiary Begins Bidding for Potential Share Issuance
China Resources Pharmaceutical Group Subsidiary Records Rise in Nine-Month Attributable Profit
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue
CR Boya Bio-Pharmaceutical's January-September Profit Increases
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%
China Resources Pharma's Profit Marginally Rises in H1
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 3320
  4. Noticias China Resources Pharmaceutical Group Limited
  5. Otros idiomas